Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
about
Body mass index, prostate cancer-specific mortality, and biochemical recurrence: a systematic review and meta-analysisDiabetes and mortality in patients with prostate cancer: a meta-analysisPreoperative glycemic control status as a significant predictor of biochemical recurrence in prostate cancer patients after radical prostatectomyDiabetes and outcomes after radical prostatectomy: are results affected by obesity and race? Results from the shared equal-access regional cancer hospital database.Energetics in colorectal and prostate cancer.Increased risk of cancer in patients with type 2 diabetes mellitus: a retrospective cohort study in China.Clinical management and burden of prostate cancer: a Markov Monte Carlo model.Does pre-existing diabetes affect prostate cancer prognosis? A systematic review.Cancer incidence in patients with type 2 diabetes mellitus: a population-based cohort study in Shanghai.Obesity is associated with castration-resistant disease and metastasis in men treated with androgen deprivation therapy after radical prostatectomy: results from the SEARCH databaseLong-term (10-year) gastrointestinal and genitourinary toxicity after treatment with external beam radiotherapy, radical prostatectomy, or brachytherapy for prostate cancer.The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancerHyperglycemia and prostate cancer recurrence in men treated for localized prostate cancerObesity and prostate cancer-specific mortality after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.Risk-based prostate cancer screening.Diabetes and cancer (2): evaluating the impact of diabetes on mortality in patients with cancer.Risk-based prostate cancer screening: who and how?Concept and viability of androgen annihilation for advanced prostate cancer.Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies.Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer.The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome.The ExPeCT (Examining Exercise, Prostate Cancer and Circulating Tumour Cells) trial: study protocol for a randomised controlled trial.Diabetes predicts metastasis after radical prostatectomy in obese men: results from the SEARCH database.Efficacy versus effectiveness study design within the European screening trial for prostate cancer: consequences for cancer incidence, overall mortality and cancer-specific mortality.
P2860
Q24625223-0A903144-E88C-4AEA-BA2B-5C029A54B9DAQ28072665-CE3021D5-97B2-4A6D-96DF-B937EC6AAB8AQ28546623-6238CACE-30E9-4245-8764-8297F627C4D2Q33586654-2B6B7F82-4F3B-4889-9A0F-C1812F6B9D60Q34315768-F040BE2B-5E08-47B2-A939-CCA3A7C7F348Q34354362-408470CF-E842-4439-81B3-3A0F783D639BQ34634410-15F147B0-2D6B-4ECB-AB9F-16486551FB31Q34904669-DF449329-AC17-4D1F-A136-226851CD8743Q35833801-4A8D4A3B-F660-43C6-A6BE-47957C7140B7Q35931460-9737EA6D-B24C-4570-8F06-8AD31630A433Q35936700-9129803F-87FB-49DE-9947-424CB5B6CD6EQ36090379-86750F80-577A-45E5-B430-D8C1F914C77AQ37120159-9F0A5215-C1E9-4B65-9270-A0B44F0A12DDQ37636973-587470F8-BE84-4351-A0CA-BA69C2C981A0Q37963657-E0AD1C54-848D-4952-845E-F8EBDEEA19D2Q38000089-B068E54C-187F-4AA1-AF84-B321D70D07ACQ38093463-F38F3E51-79C4-4F19-A373-3D6A3D6320EFQ38207556-99532011-BAD6-4D3F-A166-CCC56F704AA0Q38234432-3EEEFD88-6018-4845-AC12-C22105FA017AQ40782810-901B62DB-0804-4B98-BEF0-567DFECC524BQ41582971-1FB4FA59-0854-4D20-95D8-AE4717371D7BQ42278934-0CF895CD-8954-45B6-96E2-7261FFCF8C6CQ43478062-28CF819E-C3FD-4F98-84AC-4320FDE210CBQ48367260-125751AF-31E1-492A-A092-C4A6B36E3203
P2860
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
@en
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
@nl
type
label
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
@en
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
@nl
prefLabel
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
@en
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
@nl
P2093
P2860
P356
P1476
Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.
@en
P2093
Gerald E Hanks
Howard M Sandler
Jason A Efstathiou
Kyounghwa Bae
Matthew R Smith
Miljenko V Pilepich
William U Shipley
P2860
P304
P356
10.1200/JCO.2008.16.5845
P407
P577
2008-09-01T00:00:00Z